173 related articles for article (PubMed ID: 14684203)
1. Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration.
Lodi R; Setola E; Tonon C; Ambrosetto P; Franceschi E; Crinò L; Barbiroli B; Cortelli P
Magn Reson Imaging; 2003 Nov; 21(9):1003-7. PubMed ID: 14684203
[TBL] [Abstract][Full Text] [Related]
2. Nocardia abscesses mimicking tumor progression in gliomatosis cerebri responding to temozolomide.
Bertero L; Cassoni P; Rudà R
J Neurooncol; 2015 Jan; 121(1):225-7. PubMed ID: 25189790
[No Abstract] [Full Text] [Related]
3. Possible efficacy of temozolomide in a patient with gliomatosis cerebri.
Benjelloun A; Delavelle J; Lazeyras F; Dietrich PY
Neurology; 2001 Nov; 57(10):1932-3. PubMed ID: 11723300
[No Abstract] [Full Text] [Related]
4. Initial chemotherapy in gliomatosis cerebri.
Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
[TBL] [Abstract][Full Text] [Related]
5. Response to low dose temozolomide in radiation induced gliomatosis cerebri.
Hargrave D; Bouffet E; Gammon J; Becker L; Rutka J; Baruchel S
Med Pediatr Oncol; 2003 Dec; 41(6):562-4. PubMed ID: 14595716
[No Abstract] [Full Text] [Related]
6. Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide.
Levin N; Gomori JM; Siegal T
Neurology; 2004 Jul; 63(2):354-6. PubMed ID: 15277636
[TBL] [Abstract][Full Text] [Related]
7. Gliomatosis cerebri: better definition, better treatment.
Chamberlain MC
Neurology; 2004 Jul; 63(2):204-5. PubMed ID: 15277608
[No Abstract] [Full Text] [Related]
8. Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.
Mattox AK; Lark AL; Adamson DC
Clin Neurol Neurosurg; 2012 May; 114(4):299-306. PubMed ID: 22341931
[TBL] [Abstract][Full Text] [Related]
9. First experiences with low-dose anti-angiogenic treatment in gliomatosis cerebri with signs of angiogenic activity.
Seiz M; Kohlhof P; Brockmann MA; Neumaier-Probst E; Hermes P; VON Deimling A; Vajkoczy P; Schmieder K; Tuettenberg J
Anticancer Res; 2009 Aug; 29(8):3261-7. PubMed ID: 19661344
[TBL] [Abstract][Full Text] [Related]
10. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.
Galanaud D; Chinot O; Nicoli F; Confort-Gouny S; Le Fur Y; Barrie-Attarian M; Ranjeva JP; Fuentès S; Viout P; Figarella-Branger D; Cozzone PJ
J Neurosurg; 2003 Feb; 98(2):269-76. PubMed ID: 12593610
[TBL] [Abstract][Full Text] [Related]
11. Gliomatosis cerebri.
Gleizniene R; Bucinskas U; Lukosevicius S; Vaitkus A; Letautiene S; Apanaviciūte D; Galvonaite M
Medicina (Kaunas); 2010; 46(5):341-4. PubMed ID: 20679750
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.
Inoue T; Kumabe T; Kanamori M; Sonoda Y; Watanabe M; Tominaga T
Neurosurg Rev; 2010 Apr; 34(2):197-208. PubMed ID: 21301914
[TBL] [Abstract][Full Text] [Related]
13. [Gliomatosis cerebri].
Sanson M; Napolitano M; Cartalat-Carel S; Taillibert S
Rev Neurol (Paris); 2005 Feb; 161(2):173-81. PubMed ID: 15798516
[TBL] [Abstract][Full Text] [Related]
14. Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels.
Saraf-Lavi E; Bowen BC; Pattany PM; Sklar EM; Murdoch JB; Petito CK
AJNR Am J Neuroradiol; 2003 May; 24(5):946-51. PubMed ID: 12748099
[TBL] [Abstract][Full Text] [Related]
15. A pediatric case of anaplastic astrocytoma with a gliomatosis cerebri; the growth pattern and changes in serum VEGF-121 levels after bevacizumab treatment.
Ninomiya H; Ozeki M; Matsuzawa Y; Nozawa A; Yasue S; Kubota K; Endo S; Asano T; Taguchi K; Ohe N; Matsuo M; Iwama T; Ohnishi H
J Clin Neurosci; 2020 Nov; 81():431-433. PubMed ID: 33222957
[TBL] [Abstract][Full Text] [Related]
16. Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy.
Murphy PS; Viviers L; Abson C; Rowland IJ; Brada M; Leach MO; Dzik-Jurasz AS
Br J Cancer; 2004 Feb; 90(4):781-6. PubMed ID: 14970853
[TBL] [Abstract][Full Text] [Related]
17. Role of proton magnetic resonance spectroscopy in the diagnosis of gliomatosis cerebri: a unique pattern of normal choline but elevated Myo-inositol metabolite levels.
Mohana-Borges AV; Imbesi SG; Dietrich R; Alksne J; Amjadi DK
J Comput Assist Tomogr; 2004; 28(1):103-5. PubMed ID: 14716242
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of temozolomide using an extended continuous oral schedule.
Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
[TBL] [Abstract][Full Text] [Related]
19. Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide: case report and literature review.
Hansen N; Wittig A; Hense J; Kastrup O; Gizewski ER; Van de Nes JA
Eur J Med Res; 2011 Sep; 16(9):415-9. PubMed ID: 22024443
[TBL] [Abstract][Full Text] [Related]
20. Bilateral ptosis as initial presentation of gliomatosis cerebri: case report.
Kovanda T; Braca J; Prabhu V
J Neurol Surg A Cent Eur Neurosurg; 2013 Dec; 74 Suppl 1():e159-65. PubMed ID: 23427031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
